Mucin promotes rapid surface motility in pseudomonas aeruginosa

mBio

Volumn 3, Issue 3, 2012, Pages

  Yeung, Amy T Y ^a   Parayno, Alicia ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA; CARBON; MUCIN; NITROGEN; RHAMNOLIPID;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL FLAGELLUM; BACTERIAL GROWTH; BACTERIAL MOTILITY; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM PILUS; CARBON SOURCE; CELL COMMUNICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; INTRACELLULAR SIGNALING; LUBRICATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; VISCOSITY;

PSEUDOMONAS AERUGINOSA;

EID: 84863477079     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00073-12     Document Type: Article

References (46)

1. Cao H, Baldini RL, Rahme LG. 2001. Common mechanisms for pathogens of plants and animals. Annu. Rev. Phytopathol. 39:259-284.
2. Hutchison ML, Govan JR. 1999. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect. 1:1005-1014.
3. Montie TC, Doyle-Huntzinger D, Craven RC, Holder IA. 1982. Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect. Immun. 38: 1296-1298.
4. Hancock REW, Speert DP. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist. Update 3:2622-2630.
5. Drake D, Montie TC. 1988. Flagella, motility and invasive virulence of Pseudomonas aeruginosa. Microbiology 134:43-52.
6. Feldman M, et al. 1998. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66:43-51.
7. O'Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:295-304.
8. Harshey RM. 2003. Bacterial motility on a surface: many ways to a common goal. Annu. Rev. Microbiol. 57:249-273.
9. Mattick JS. 2002. Type IV pili and twitching motility. Annu. Rev. Microbiol. 56:289-314.
10. Köhler T, Curty LK, Barja F, van Delden C, Pechère JC. 2000. Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 182:5990-5996.
11. Overhage J, Bains M, Brazas MD, Hancock REW. 2008. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J. Bacteriol. 190: 2671-2679.
12. Yeung ATY, et al. 2009. Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR. J. Bacteriol. 191:5592-5602.
13. Déziel E, Lépine F, Milot S, Villemur R. 2003. rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids. Microbiology 149:2005-2013.
14. Daniels R, Vanderleyden J, Michiels J. 2004. Quorum sensing and swarming migration in bacteria. FEMS Microbiol. Rev. 28:261-289.
15. Murray TS, Kazmierczak BI. 2008. Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J. Bacteriol. 190:2700-2708.
16. Thornton DJ, et al. 1996. Respiratory mucins: identification of core proteins and glycoforms. Biochem. J. 316(Pt 3):967-975.
17. Kaliner M, et al. 1986. Human respiratory mucus. Am. Rev. Respir. Dis. 134:612- 621.
18. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087.
19. Fung C, et al. 2010. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J. Med. Microbiol. 59:1089-1100.
20. Sriramulu DD, Lünsdorf H, Lam JS, Römling U. 2005. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 54:667-676.
21. Toutain CM, Zegans ME, O'Toole GA. 2005. Evidence for two flagellar stators and their role in the motility of Pseudomonas aeruginosa. J. Bacteriol. 187:771-777.
22. Chugani SA, et al. 2001. QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 98:2752-2757.
23. Ledgham F, et al. 2003. Interactions of the quorum sensing regulator QscR: interaction with itself and the other regulators of Pseudomonas aeruginosa LasR and RhlR. Mol. Microbiol. 48:199-210.
24. McPhee JB, Lewenza S, Hancock REW. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
25. Lee S, Müller M, Rezwan K, Spencer ND. 2005. Porcine gastric mucin (PGM) at the water/poly(dimethylsiloxane) (PDMS) interface: influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties. Langmuir 21:8344-8353.
26. Yakubov GE, McColl J, Bongaerts JHH, Ramsden JJ. 2009. Viscous boundary lubrication of hydrophobic surfaces by mucin. Langmuir 25: 2313-2321.
27. Park MS, Chung JW, Kim YK, Chung SC, Kho HS. 2007. Viscosity and wettability of animal mucin solutions and human saliva. Oral Dis. 13: 181-186.
28. Hatano K, Matsumoto T, Furuya N, Hirakata Y, Tateda K. 1996. Role of motility in the endogenous Pseudomonas aeruginosa sepsis after burn. J. Infect. Chemother. 2:240-246.
29. Henke MO, John G, Germann M, Lindemann H, Rubin BK. 2007. MUC5ACandMUC5Bmucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 175: 816-821.
30. King M. 2005. Mucus and its role in airway clearance and cytoprotection, p 409-416. In Hamid Q, et al. (ed.), Physiologic basis of respiratory disease. BC Decker, Hamilton, Ontario, Canada.
31. Phillips JE, et al. 2006. An enzyme-linked immunosorbent assay (ELISA) for the determination of mucin levels in bronchoalveolar lavage fluid. J. Pharmacol. Toxicol. Methods 53:160-167.
32. Nelson JW, et al. 1990. Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect. Immun. 58:1489-1495.
33. Brandt T, Breitenstein S, von der Hardt H, Tümmler B. 1995. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 50:880-882.
34. Kim J-S, Hackley GH, Okamoto K, Rubin BK. 2001. Sputum processing for evaluation of inflammatory mediators. Pediatr. Pulmonol. 32: 152-158.
35. Sanders NN, et al. 2000. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am. J. Respir. Crit. Care Med. 162:1905-1911.
36. Lai SK, Wang Y-Y, Wirtz D, Hanes J. 2009. Micro- and macrorheology of mucus. Adv. Drug Deliv. Rev. 61:86-100.
37. Wu Y, Jiang Y, Kaiser AD, Alber M. 2011. Self-organization in bacterial swarming: lessons from myxobacteria. Phys. Biol. 8:1-10.
38. Kirisits MJ, Parsek MR. 2006. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities? Cell. Microbiol. 8:1841-1849.
39. Gooderham WJ, et al. 2009. The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 155:699-711.
40. Jyot J, et al. 2011. Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J. Infect. Dis. 203:1367-1377.
41. Kipnis E, Sawa T, Wiener-Kronish J. 2006. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med. Mal. Infect. 36:78-91.
42. Nizet V. 2006. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 8:11-26.
43. Liberati NT, et al. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U. S. A. 103:2833-2838.
44. Jacobs MA, et al. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:14339-14344.
45. Mitsui Y, Matsumura K, Kondo C, Takashima R. 1976. The role of mucin on experimental Pseudomonas keratitis in rabbits. Invest. Ophthalmol. 15:208-210.
46. Brandt T, Breitenstein S, von der Hardt H, Tümmler B. 1995. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 50:880-882.s